MCRB vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 05, 2026

MCRB

33.3
AI Score
VS
CLYM Wins

CLYM

43.3
AI Score

Investment Advisor Scores

MCRB

33score
Recommendation
SELL

CLYM

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MCRB CLYM Winner
Net Income -250.16M -27.22M CLYM
Operating Income -179.91M -30.57M CLYM
ROE -2319.9% -11.4% CLYM
ROA -71.7% -11.1% CLYM
Total Assets 348.78M 246.29M MCRB
Cash 163.03M 44.11M MCRB
Current Ratio 2.28 31.45 CLYM
Free Cash Flow -238.64M -25.18M CLYM

Relative Price Performance (Last 90 Days)

MCRB 1M: +18.7% · 3M: -13.7% CLYM 1M: +10.9% · 3M: +47.1%

Current Technical Phase

MCRB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.1 · Price: $5.72

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.9% over 20 days), RSI 54

RSI (14): 53.5 · Price: $15.52

Fundamentals Snapshot

Metric MCRB CLYM
Market Cap
Forward P/E -1.2 -14.8
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin -24.5%
Operating Margin -21.0% 0.0%
EPS -2.42 -0.80
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.